Published in Cesk Slov Oftalmol on January 01, 2007
[Ferritin, oxidative stress and coronary atherosclerosis]. Vnitr Lek (2004) 2.08
Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. Diabetologia (2005) 1.60
[Glibenclamide instead of insulin: a new chance for MODY 3 type diabetes patients: case report]. Vnitr Lek (2006) 1.42
The role of ABC transporters in progression and clinical outcome of colorectal cancer. Mutagenesis (2012) 1.28
Formation of indigo by recombinant mammalian cytochrome P450. Biochem Biophys Res Commun (1999) 1.24
Tumor risk in disorders of sex development. Sex Dev (2010) 1.17
Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples. Drug Metab Dispos (1998) 1.15
Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents. Eur J Pediatr (2006) 1.11
Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations. Br J Cancer (2004) 1.11
Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia. Eur J Endocrinol (2005) 1.09
Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Hum Mol Genet (2001) 1.08
Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study. Horm Res (2001) 1.06
Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur J Clin Microbiol Infect Dis (2014) 1.04
Gonadal pathology and tumor risk in relation to clinical characteristics in patients with 45,X/46,XY mosaicism. J Clin Endocrinol Metab (2011) 1.03
Genetic epidemiology of MODY in the Czech republic: new mutations in the MODY genes HNF-4alpha, GCK and HNF-1alpha. Diabetologia (2003) 1.03
Localization of male-specifically expressed MROS genes of Silene latifolia by PCR on flow-sorted sex chromosomes and autosomes. Genetics (2001) 0.91
Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED. Hum Mutat (2001) 0.90
Relationship between the capacity to repair 8-oxoguanine, biomarkers of genotoxicity and individual susceptibility in styrene-exposed workers. Mutat Res (2007) 0.89
Colchicine biotransformation by human liver microsomes. Identification of CYP3A4 as the major isoform responsible for colchicine demethylation. Biochem Pharmacol (1997) 0.88
Association between genetic polymorphisms and biomarkers in styrene-exposed workers. Mutat Res (2001) 0.87
Serological markers of Chlamydia pneumoniae, cytomegalovirus and Helicobacter pylori infection in diabetic and non-diabetic patients with unstable angina pectoris. Cent Eur J Public Health (2003) 0.86
An evaluation of styrene genotoxicity using several biomarkers in a 3-year follow-up study of hand-lamination workers. Mutat Res (1999) 0.86
Genetic polymorphisms of biotransformation enzymes: allele frequencies in the population of the Czech Republic. Pharmacogenetics (2000) 0.86
Effects of sleep deprivation on the activity of selected metabolic enzymes in skeletal muscle. Eur J Appl Physiol Occup Physiol (1981) 0.86
Genotype and haplotype analysis of TP53 gene and the risk of pancreatic cancer: an association study in the Czech Republic. Carcinogenesis (2010) 0.85
The relationship between central serotonergic activity and insulin sensitivity in healthy volunteers. Psychoneuroendocrinology (1999) 0.85
Flexibility and stability of the structure of cytochromes P450 3A4 and BM-3. Eur J Biochem (2000) 0.85
Cerebrospinal fluid cytologic findings in multiple sclerosis. A comparison between patient subgroups. Acta Cytol (2001) 0.84
Gustometry of diabetes mellitus patients and obese patients. Int Tinnitus J (1999) 0.84
Biomonitoring of occupational exposure to styrene in a plastics lamination plant. Mutat Res (1999) 0.84
Cytotoxicity of cyclophosphamide, paclitaxel, and docetaxel for tumor cell lines in vitro: effects of concentration, time and cytochrome P450-catalyzed metabolism. Arch Toxicol (2000) 0.83
Prepubertal girls with Turner syndrome and children with isolated SHOX deficiency have similar bone geometry at the radius. J Clin Endocrinol Metab (2013) 0.83
Metabolism of benzene in human liver microsomes: individual variations in relation to CYP2E1 expression. Arch Toxicol (1999) 0.82
Metabolism of new-generation taxanes in human, pig, minipig and rat liver microsomes. Xenobiotica (2006) 0.82
The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus. Diabet Med (2013) 0.82
Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries. J Clin Endocrinol Metab (2001) 0.81
The role of various biomarkers in the evaluation of styrene genotoxicity. Cancer Detect Prev (2003) 0.81
Congenital adrenal hyperplasia: lessons from a multinational study. Horm Res (2002) 0.81
Six novel mutations in the GCK gene in MODY patients. Clin Genet (2007) 0.81
Premenarchal and postmenarchal girls with insulin-dependent diabetes mellitus: ovarian and other organ-specific autoantibodies, menstrual cycle. J Pediatr Adolesc Gynecol (1999) 0.80
Thyroid autoimmunity in children with coexisting type 1 diabetes mellitus and celiac disease: a multicenter study. J Pediatr Endocrinol Metab (2006) 0.80
[Breast cancer: an overview of factors affecting the onset and development of the disease]. Cas Lek Cesk (2002) 0.80
45,X/46,X,psu dic(Y) gonadal dysgenesis: influence of the two cell lines on the clinical phenotype, including gonadal histology. Sex Dev (2013) 0.80
Myocardial amino acid metabolism in patients with chronic ischemic heart disease. Basic Res Cardiol (1978) 0.80
The role of CYP2E1 and 2B1 in metabolic activation of benzene derivatives. Arch Toxicol (1996) 0.80
Three novel mutations in MODY and its phenotype in three different Czech families. Diabetes Res Clin Pract (2010) 0.80
Ornithine decarboxylase G316A genotype and colorectal cancer risk. Colorectal Dis (2010) 0.80
Bone geometry and volumetric bone density at the radius in patients with isolated SHOX deficiency. Exp Clin Endocrinol Diabetes (2013) 0.79
Comparison of in vitro activities of biotransformation enzymes in pig, cattle, goat and sheep. Res Vet Sci (2004) 0.79
GH and TSH deficiency. Exp Clin Endocrinol Diabetes (1997) 0.79
Analysis of rapid oscillations of glucose and free fatty acids in plasma. Eur J Appl Physiol Occup Physiol (1979) 0.79
Long-term results of pars plana vitrectomy and silicone oil for giant tears. Eur J Ophthalmol (1997) 0.79
CYP1B1 gene polymorphism modifies pancreatic cancer risk but not survival. Neoplasma (2010) 0.78
Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterised by decreased fasting and stimulated levels of insulin, glucagon and glucagon-like peptide (GLP)-1. Diabetologia (2011) 0.78
Acute phase proteins and prognostic inflammatory and nutritional index (PINI) in moderately burned children aged up to 3 years. Burns (1990) 0.78
Lack of PAX4 mutations in 53 Czech MODYX families. Diabet Med (2010) 0.77
Validation of a mathematical model predicting the response to growth hormone treatment in prepubertal children with idiopathic growth hormone deficiency. Horm Res (2003) 0.77
Exposure to various benzene derivatives differently induces cytochromes P450 2B1 and P450 2E1 in rat liver. Arch Toxicol (1993) 0.77
Boys with haemophilia have low trabecular bone mineral density and sarcopenia, but normal bone strength at the radius. Haemophilia (2011) 0.77
[The contrast sensitivity test in early detection of ocular changes in children, teenagers, and young adults with diabetes mellitus type I]. Cesk Slov Oftalmol (2006) 0.77
The association between glutathione S-transferase gene polymorphisms and pancreatic cancer in a central European Slavonic population. Mutat Res (2009) 0.77
Cytochromes P450 in benzene metabolism and involvement of their metabolites and reactive oxygen species in toxicity. Environ Health Perspect (1996) 0.77
[The human lens' transparence changes in children, adolescents, and young adults with diabetes mellitus type I]. Cesk Slov Oftalmol (2006) 0.77
Cytochrome P450 catalyzed oxidation of monochlorobenzene, 1,2- and 1,4-dichlorobenzene in rat, mouse, and human liver microsomes. Chem Biol Interact (1998) 0.77
Body composition in children receiving recombinant human growth hormone after renal transplantation. Kidney Int (1998) 0.76
Treatment options for children with monogenic forms of obesity. World Rev Nutr Diet (2013) 0.76
Effect of ivermectin on activities of cytochrome P450 isoenzymes in mouflon (Ovis musimon) and fallow deer (Dama dama). Chem Biol Interact (2001) 0.76
Insulin lispro improves postprandial glucose control in patients with diabetes mellitus. Sb Lek (2002) 0.76
Artificially low cortical bone mineral density in Turner syndrome is due to the partial volume effect. Osteoporos Int (2014) 0.76
[Growth and adult height in patients with congenital adrenal hyperplasia]. Cas Lek Cesk (1995) 0.76
Prevalence of coronary atherosclerosis in asymptomatic population. Eur Heart J (2000) 0.75
[Discussion of the article by P. Dlouhý, M. Andĕl: Trans fatty acids in the diet their possible health risks. Cas Lek Cesk (1999) 0.75
[The Budd-Chiari syndrome in a patient with primary thrombocythemia treated with interferon alfa and transjugular portosystemic shunt]. Cas Lek Cesk (2004) 0.75
[Glucagon and the metabolism under intense physical load (author's transl)]. Cas Lek Cesk (1976) 0.75
[Calculation of the costs of drugs, medical materials, certain medical procedures and social services for patients with diabetic foot syndrome]. Vnitr Lek (2003) 0.75
[Fatty acid composition of domestic dietary fats]. Sb Lek (2000) 0.75
[Cyproterone acetate in the treatment of girls with central precocious puberty]. Cesk Pediatr (1991) 0.75
Indicators of risk of ischaemic heart disease in patients with acute myocardial infarction under 65 years and their relatives. Cent Eur J Public Health (1998) 0.75
[Genetic risk factors in autoimmune diabetes mellitus, their significance and function]. Cas Lek Cesk (2004) 0.75
[Recreational-educational camps for children with diabetes]. Cesk Pediatr (1988) 0.75
[Association of HLA molecules with autoimmune diseases]. Cas Lek Cesk (2002) 0.75
[Present views on therapy with growth hormone]. Cesk Pediatr (1988) 0.75
[What do we owe the families of diabetic children?]. Cesk Pediatr (1989) 0.75
[Tryptophan, its metabolism and function in the human body (with emphasis on metabolic diseases and depressive syndromes)]. Vnitr Lek (1998) 0.75
[Levels of heavy metals in the environment around Prague]. Cas Lek Cesk (1986) 0.75
[Disorders of sexual development (2 case report, delayed diagnosis)]. Cesk Pediatr (1990) 0.75
[Sonographic measurement of intimal thickness of the common carotid artery in diabetics]. Vnitr Lek (1999) 0.75
[Treatment of diabetics using portable insulin pumps]. Cesk Pediatr (1985) 0.75
[Methods for identification of HLA antigen polymorphisms]. Cas Lek Cesk (2002) 0.75
Serum ferritin levels in subjects at high risk of atherosclerosis. Cent Eur J Public Health (2000) 0.75
[Long-term therapy of central precocious puberty in girls with the gonadoliberin analog D-Trp-6-LHRH after prior therapy with cyproterone acetate]. Cesk Pediatr (1994) 0.75
[Improvement in the prognosis for growth in a boy with central precocious puberty and growth hormone deficiency treated concurrently with growth hormone and D-Trp-6-LHRH gonadoliberin analog]. Cesk Pediatr (1994) 0.75
[Parenteral glutamine does not improve the nutritional status in patients during high-dose chemotherapy and autologous peripheral stem cell transplantation]. Vnitr Lek (2002) 0.75
[Intestinal cryptosporidiosis in a 14-year-old girl with a malabsorption syndrome and an obscure acquired defect of immunity]. Cesk Pediatr (1987) 0.75
[Signs of active infection with Chlamydia pneumoniae in patients with coronary heart disease]. Cas Lek Cesk (2004) 0.75
[The effect of food supplementation with organically bound chromium on indicators of compensation in diabetic children and adolescents]. Cesk Pediatr (1992) 0.75